Telix Pharmaceuticals Ltd
ASX:TLX

Watchlist Manager
Telix Pharmaceuticals Ltd Logo
Telix Pharmaceuticals Ltd
ASX:TLX
Watchlist
Price: 14.285 AUD -0.24%
Market Cap: 4.8B AUD

Wall Street
Price Targets

TLX Price Targets Summary
Telix Pharmaceuticals Ltd

Wall Street analysts forecast TLX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLX is 28.338 AUD with a low forecast of 22.826 AUD and a high forecast of 36.75 AUD.

Lowest
Price Target
22.826 AUD
60% Upside
Average
Price Target
28.338 AUD
98% Upside
Highest
Price Target
36.75 AUD
157% Upside
Telix Pharmaceuticals Ltd Competitors:
Price Targets
EXEL
Exelixis Inc
10% Upside
XFOR
X4 Pharmaceuticals Inc
124% Upside
RIGL
Rigel Pharmaceuticals Inc
9% Upside
MGX
Metagenomi Inc
432% Upside
ARQT
Arcutis Biotherapeutics Inc
8% Upside
87S
Roivant Sciences Ltd
18% Upside
IVVD
Invivyd Inc
202% Upside
ALDX
Aldeyra Therapeutics Inc
106% Upside

Revenue
Forecast

Revenue Estimate
Telix Pharmaceuticals Ltd

For the last 6 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 271%. The projected CAGR for the next 3 years is 32%.

271%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-34%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 39%.

N/A
Past Growth
39%
Estimated Growth
Estimates Accuracy
11%
Average Beat

Net Income
Forecast

Net Income Estimate
Telix Pharmaceuticals Ltd

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 3 years is 47%.

N/A
Past Growth
47%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLX's stock price target?
Price Target
28.338 AUD

According to Wall Street analysts, the average 1-year price target for TLX is 28.338 AUD with a low forecast of 22.826 AUD and a high forecast of 36.75 AUD.

What is Telix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
32%

For the last 6 years the compound annual growth rate for Telix Pharmaceuticals Ltd's revenue is 271%. The projected CAGR for the next 3 years is 32%.

What is Telix Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
39%

The compound annual growth rate of Telix Pharmaceuticals Ltd's operating income for the next 3 years is 39%.

What is Telix Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
47%

The compound annual growth rate of Telix Pharmaceuticals Ltd's net income for the next 3 years is 47%.

Back to Top